{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:34:52Z","timestamp":1791048892400,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,4]]},"DOI":"10.7759\/cureus.96083","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:20:50Z","timestamp":1762269650000},"source":"Crossref","is-referenced-by-count":1,"title":["The Practical Management of Intractable Haematuria Within the National Health Service of the United Kingdom: A Literature Review"],"prefix":"10.7759","author":[{"given":"Toni","family":"Mihailidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2000.00900.x","article-title":"The management of intractable haematuria","volume":"86","author":"Choong SK","year":"2000","unstructured":"Choong SK, Walkden M, Kirby R. The management of intractable haematuria. BJU Int. 2000, 86:951-9. 10.1046\/j.1464-410x.2000.00900.x","journal-title":"BJU Int"},{"key":"ref2","article-title":"Hemorrhagic cystitis: a review of the literature and treatment options","volume":"29","author":"D'Amico MJ","year":"2022","unstructured":"D'Amico MJ, Foss H, Uhr A, Rudnick B, Kloniecke E, Gomella LG. Hemorrhagic cystitis: a review of the literature and treatment options. Can J Urol. 2022, 29:11276-83.","journal-title":"Can J Urol"},{"key":"ref3","article-title":"","year":"2019","unstructured":"Oxford Handbook of Urology. Biers S, Reynard J (ed). Oxford University Press, Oxford, United Kingdom; 2019. https:\/\/academic.oup.com\/book\/60841."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.65380","article-title":"Hemorrhagic cystitis: a challenge to the urologist","volume":"26","author":"Manikandan R","year":"2010","unstructured":"Manikandan R, Kumar S, Dorairajan LN. Hemorrhagic cystitis: a challenge to the urologist. Indian J Urol. 2010, 26:159-66. 10.4103\/0970-1591.65380","journal-title":"Indian J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16140","article-title":"Haemorrhagic cystitis: a review of management strategies and emerging treatments","volume":"132","author":"Li KD","year":"2023","unstructured":"Li KD, Jones CP, Hakam N, Erickson BA, Vanni AJ, Chancellor MB, Breyer BN. Haemorrhagic cystitis: a review of management strategies and emerging treatments. BJU Int. 2023, 132:631-7. 10.1111\/bju.16140","journal-title":"BJU Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2014.0655","article-title":"Hemorrhagic cystitis requiring bladder irrigation is associated with poor mortality in hospitalized stem cell transplant patients","volume":"41","author":"Raup VT","year":"2015","unstructured":"Raup VT, Potretzke AM, Manley BJ, Brockman JA, Bhayani SB. Hemorrhagic cystitis requiring bladder irrigation is associated with poor mortality in hospitalized stem cell transplant patients. Int Braz J Urol. 2015, 41:1126-31. 10.1590\/S1677-5538.IBJU.2014.0655","journal-title":"Int Braz J Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2010.23","article-title":"Management of radiation cystitis","volume":"7","author":"Smit SG","year":"2010","unstructured":"Smit SG, Heyns CF. Management of radiation cystitis. Nat Rev Urol. 2010, 7:206-14. 10.1038\/nrurol.2010.23","journal-title":"Nat Rev Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1994.1278","article-title":"Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix","volume":"55","author":"Levenback C","year":"1994","unstructured":"Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DM. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994, 55:206-10. 10.1006\/gyno.1994.1278","journal-title":"Gynecol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2018.07.017","article-title":"Urologic complications following pelvic radiotherapy","volume":"122","author":"Lobo N","year":"2018","unstructured":"Lobo N, Kulkarni M, Hughes S, Nair R, Khan MS, Thurairaja R. Urologic complications following pelvic radiotherapy. Urology. 2018, 122:1-9. 10.1016\/j.urology.2018.07.017","journal-title":"Urology"},{"key":"ref10","article-title":"Alum irrigation for the treatment of intractable haematuria","volume":"16","author":"Ho CC","year":"2009","unstructured":"Ho CC, Md Zainuddin Z. Alum irrigation for the treatment of intractable haematuria. Malays J Med Sci. 2009, 16:66-8.","journal-title":"Malays J Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2015.0588","article-title":"Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: a contemporary evaluation","volume":"42","author":"Westerman ME","year":"2016","unstructured":"Westerman ME, Boorjian SA, Linder BJ. Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: a contemporary evaluation. Int Braz J Urol. 2016, 42:1144-9. 10.1590\/S1677-5538.IBJU.2015.0588","journal-title":"Int Braz J Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)53282-6","article-title":"Alum irrigation for the control of massive bladder hemorrhage","volume":"1","author":"Ostroff EB","year":"1982","unstructured":"Ostroff EB, Chenault OW. Alum irrigation for the control of massive bladder hemorrhage. J Urol. 1982, 1:929-30. 10.1016\/s0022-5347(17)53282-6","journal-title":"J Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1987.tb05487.x","article-title":"Treatment of massive haematuria with aluminous salts","volume":"60","author":"Arrizabalaga M","year":"1987","unstructured":"Arrizabalaga M, Extramiana J, Parra JL, Ramos C, D\u00edaz Gonz\u00e1lez R, Leiva O. Treatment of massive haematuria with aluminous salts. Br J Urol. 1987, 60:223-6. 10.1111\/j.1464-410x.1987.tb05487.x","journal-title":"Br J Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(12)80719-0","article-title":"Acute aluminum toxicity and alum bladder irrigation in patients with renal failure","volume":"21","author":"Perazella M","year":"1993","unstructured":"Perazella M, Brown E. Acute aluminum toxicity and alum bladder irrigation in patients with renal failure. Am J Kidney Dis . 1993, 21:44-6. 10.1016\/s0272-6386(12)80719-0","journal-title":"Am J Kidney Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90014-4","article-title":"Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia","volume":"322","author":"Wills MR","year":"1983","unstructured":"Wills MR, Savory J. Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia. Lancet. 1983, 322:29-34. 10.1016\/S0140-6736(83)90014-4","journal-title":"Lancet"},{"key":"ref16","article-title":"Topical Silver Nitrate for the Management of Hemostasis: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines","author":"Ho C","year":"2018","unstructured":"Ho C, Arg\u00e1ez C. Topical Silver Nitrate for the Management of Hemostasis: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON); 2018."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2020.110365","article-title":"The addition of silver nitrate cautery to antiseptic nasal cream for patients with epistaxis: a systematic review and meta-analysis","volume":"138","author":"Alsaif A","year":"2020","unstructured":"Alsaif A, Karam M, Alhaider A, Almazeedi A, Aldubaikhi A, Alfayez A. The addition of silver nitrate cautery to antiseptic nasal cream for patients with epistaxis: a systematic review and meta-analysis. Int J Pediatr Otorhinolaryngol. 2020, 138:110365. 10.1016\/j.ijporl.2020.110365","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"ref18","article-title":"Intravesical silver nitrate for refractory hemorrhagic cystitis","volume":"42","author":"Montgomery BD","year":"2016","unstructured":"Montgomery BD, Boorjian SA, Ziegelmann MJ, Joyce DD, Linder BJ. Intravesical silver nitrate for refractory hemorrhagic cystitis. Turk J Urol. 2016, 42:197-201.","journal-title":"Turk J Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)58154-9","article-title":"Anuria following silver nitrate irrigation for intractable bladder hemorrhage","volume":"118","author":"Raghavaiah NV","year":"1997","unstructured":"Raghavaiah NV, Soloway MS. Anuria following silver nitrate irrigation for intractable bladder hemorrhage. J Urol. 1997, 118:681-2. 10.1016\/S0022-5347(17)58154-9","journal-title":"J Urol"},{"key":"ref20","unstructured":"Silver Nitrate. National Institute for Health and Care Excellence. (2024). Accessed: September 8, 2024: https:\/\/bnf.nice.org.uk\/drugs\/silver-nitrate\/#indications-and-dose."},{"key":"ref21","unstructured":"Carboprost. (2024). Accessed. September 8, 2024: https:\/\/bnf.nice.org.uk\/drugs\/carboprost\/."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402800508","article-title":"Treatment of cyclophosphamide-induced hemorrhagic cystitis with prostaglandins","volume":"28","author":"Miller LJ","year":"1994","unstructured":"Miller LJ, Chandler SW, Ippoliti CM. Treatment of cyclophosphamide-induced hemorrhagic cystitis with prostaglandins. Ann Pharmacother. 1994, 28:590-4. 10.1177\/106002809402800508","journal-title":"Ann Pharmacother"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)44463-6","article-title":"Prostaglandin F2-alpha bladder irrigation for control of intractable cyclophosphamide-induced hemorrhagic cystitis","volume":"137","author":"Shurafa M","year":"1987","unstructured":"Shurafa M, Shumaker E, Cronin S. Prostaglandin F2-alpha bladder irrigation for control of intractable cyclophosphamide-induced hemorrhagic cystitis. J Urol. 1987, 137:1230-1. 10.1016\/s0022-5347(17)44463-6","journal-title":"J Urol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)36192-x","article-title":"Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine","volume":"149","author":"Levine LA","year":"1993","unstructured":"Levine LA, Jarrard DF. Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine. J Urol. 1993, 149:719-23. 10.1016\/s0022-5347(17)36192-x","journal-title":"J Urol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)39875-0","article-title":"Prostaglandin E1 bladder instillations to control severe hemorrhagic cystitis","volume":"143","author":"Trigg ME","year":"1990","unstructured":"Trigg ME, O\u2019Reilly J, Rumelhart S, et al.. Prostaglandin E1 bladder instillations to control severe hemorrhagic cystitis. J Urol. 1990, 143:92-4. 10.1016\/S0022-5347(17)39875-0","journal-title":"J Urol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-1-142_1","article-title":"Treatment of cyclophosphamide-induced cystitis with prostaglandin E2","volume":"101","author":"Mohiuddin J","year":"1984","unstructured":"Mohiuddin J, Prentice HG, Schey S, Blacklock H, Dandona P. Treatment of cyclophosphamide-induced cystitis with prostaglandin E2. Ann Intern Med. 1984, 101:142. 10.7326\/0003-4819-101-1-142_1","journal-title":"Ann Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/iju.12113","article-title":"Therapeutic options for intractable hematuria in advanced bladder cancer","volume":"20","author":"Abt D","year":"2013","unstructured":"Abt D, Bywater M, Engeler DS, Schmid HP. Therapeutic options for intractable hematuria in advanced bladder cancer. Int J Urol. 2013, 20:651-60. 10.1111\/iju.12113","journal-title":"Int J Urol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(92)90479-g","article-title":"Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage","volume":"40","author":"Singh I","year":"1992","unstructured":"Singh I, Laungani GB. Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage. Urol. 1992, 40:227-9. 10.1016\/0090-4295(92)90479-g","journal-title":"Urol"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1971.00310150138020","article-title":"Aminocaproic acid treatment of prolonged hematuria following renal biopsy","volume":"127","author":"Haygood TA","year":"1971","unstructured":"Haygood TA, Atkins R, Kennedy JA, Cutler RE. Aminocaproic acid treatment of prolonged hematuria following renal biopsy. Arch Intern Med. 1971, 127:478-81.","journal-title":"Arch Intern Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOSGlobal-D-18-00072","article-title":"Intravenous tranexamic acid versus topical aminocaproic acid: which method has the least blood loss and transfusion rates?","volume":"2","author":"Lum ZC","year":"2018","unstructured":"Lum ZC, Manoukian MA, Pacheco CS, Nedopil AJ, Giordani M, Meehan JP. Intravenous tranexamic acid versus topical aminocaproic acid: which method has the least blood loss and transfusion rates?. J Am Acad Orthop Surg Glob Res Rev. 2018, 2:e072. 10.5435\/JAAOSGlobal-D-18-00072","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/2309499020959158","article-title":"Comparison between epsilon-aminocaproic acid and tranexamic acid for total hip and knee arthroplasty: a meta-analysis","volume":"28","author":"Liu WB","year":"2020","unstructured":"Liu WB, Li GS, Shen P, Zhang FJ. Comparison between epsilon-aminocaproic acid and tranexamic acid for total hip and knee arthroplasty: a meta-analysis. J Orthop Surg (Hong Kong). 2020, 28:2309499020959158. 10.1177\/2309499020959158","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13348","article-title":"The many roles of tranexamic acid: an overview of the clinical indications for TXA in medical and surgical patients","volume":"104","author":"Cai J","year":"2020","unstructured":"Cai J, Ribkoff J, Olson S, Raghunathan V, Al-Samkari H, DeLoughery TG, Shatzel JJ. The many roles of tranexamic acid: an overview of the clinical indications for TXA in medical and surgical patients. Eur J Haematol. 2020, 104:79-87. 10.1111\/ejh.13348","journal-title":"Eur J Haematol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.09.012","article-title":"Effect of tranexamic acid on gross hematuria: a pilot randomized clinical trial study","volume":"35","author":"Moharamzadeh P","year":"2017","unstructured":"Moharamzadeh P, Ojaghihaghighi S, Amjadi M, Rahmani F, Farjamnia A. Effect of tranexamic acid on gross hematuria: a pilot randomized clinical trial study. Am J Emerg Med. 2017, 35:1922-5. 10.1016\/j.ajem.2017.09.012","journal-title":"Am J Emerg Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2023.02.005","article-title":"Safety and efficacy of intravesical epinephrine instillation in patients with intractable lower urinary tract hematuria - a novel approach","volume":"175","author":"Chow YC","year":"2023","unstructured":"Chow YC, Hsu WH, Chen M, Lin WC, Chiu AW. Safety and efficacy of intravesical epinephrine instillation in patients with intractable lower urinary tract hematuria - a novel approach. Urology. 2023, 175:216-22. 10.1016\/j.urology.2023.02.005","journal-title":"Urology"},{"key":"ref35","unstructured":"Adrenaline\/epinephrine. (2024). Accessed. August 27, 2024: https:\/\/bnf.nice.org.uk\/drugs\/adrenaline-epinephrine\/."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2021.01.016","article-title":"Multicentre International Study for the Prevention with iAluRil of Radio-induced Cystitis (MISTIC): a randomised controlled study","volume":"26","author":"Redorta JP","year":"2021","unstructured":"Redorta JP, Sanguedolce F, Pardo GS, et al.. Multicentre International Study for the Prevention with iAluRil of Radio-induced Cystitis (MISTIC): a randomised controlled study. Eur Urol Open Sci. 2021, 26:45-54. 10.1016\/j.euros.2021.01.016","journal-title":"Eur Urol Open Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2022.02.013","article-title":"Intravesical instillation with glycosaminoglycan replacement treatment in patients suffering radiation-induced haemorrhagic cystitis: when and which patients can benefit most from it?","volume":"40","author":"Sanguedolce F","year":"2022","unstructured":"Sanguedolce F, Meneghetti I, Bevilacqua G, et al.. Intravesical instillation with glycosaminoglycan replacement treatment in patients suffering radiation-induced haemorrhagic cystitis: when and which patients can benefit most from it?. Urol Oncol. 2022, 40:344.e19-25. 10.1016\/j.urolonc.2022.02.013","journal-title":"Urol Oncol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10550.x","article-title":"Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis","volume":"109","author":"Shao Y","year":"2012","unstructured":"Shao Y, Lu GL, Shen ZJ. Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis. BJU Int. 2012, 109:691-4. 10.1111\/j.1464-410X.2011.10550.x","journal-title":"BJU Int"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-021-08589-6","article-title":"PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot study","volume":"36","author":"Branchi F","year":"2022","unstructured":"Branchi F, Klingenberg-Noftz R, Friedrich K, et al.. PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot study. Surg Endosc. 2022, 36:2954-61. 10.1007\/s00464-021-08589-6","journal-title":"Surg Endosc"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2020-101735","article-title":"Endoscopically delivered Purastat for the treatment of severe haemorrhagic radiation proctopathy: a service evaluation of a new endoscopic treatment for a challenging condition","volume":"12","author":"White K","year":"2021","unstructured":"White K, Henson CC. Endoscopically delivered Purastat for the treatment of severe haemorrhagic radiation proctopathy: a service evaluation of a new endoscopic treatment for a challenging condition. Frontline Gastroenterol. 2021, 12:608-13. 10.1136\/flgastro-2020-101735","journal-title":"Frontline Gastroenterol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1308\/rcsann.2023.0034","article-title":"Cystoscopic application of PuraStat(\u00ae) in the treatment of radiation-induced haemorrhagic cystitis","volume":"107","author":"Darwazeh H","year":"2025","unstructured":"Darwazeh H, Hemsworth L, Smith L, Ilie PC. Cystoscopic application of PuraStat(\u00ae) in the treatment of radiation-induced haemorrhagic cystitis. Ann R Coll Surg Engl. 2025, 107:230-2. 10.1308\/rcsann.2023.0034","journal-title":"Ann R Coll Surg Engl"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2025.103067","article-title":"Effective management of refractory haematuria using PuraStat: a case report and literature review","volume":"61","author":"Latham J","year":"2025","unstructured":"Latham J, Armstrong K, Abdelrasheed A, Shendy M, Mohamed B, Ellul T. Effective management of refractory haematuria using PuraStat: a case report and literature review. Urol Case Rep. 2025, 61:103067. 10.1016\/j.eucr.2025.103067","journal-title":"Urol Case Rep"},{"key":"ref43","article-title":"Hyperbaric Oxygen Therapy Indications: The Hyperbaric Oxygen Therapy Committee Report","year":"2014","unstructured":"Hyperbaric Oxygen Therapy Indications. The Hyperbaric Oxygen Therapy Committee Report. Weaver LK (ed): Best Publishing Company, Florida; 2014."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30494-2","article-title":"Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial.","volume":"20","author":"Oscarsson N","year":"2019","unstructured":"Oscarsson N, M\u00fcller B, Ros\u00e9n A, et al.. Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial.. Lancet Oncol . 2019, 20:1602-14. 10.1016\/S1470-2045(19)30494-2","journal-title":"Lancet Oncol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/0278-2391(92)90495-l","article-title":"Hyperbaric oxygen therapy: contraindications and complications","volume":"50","author":"Foster JH","year":"1992","unstructured":"Foster JH. Hyperbaric oxygen therapy: contraindications and complications. J Oral Maxillofac Surg. 1992, 50:1081-6. 10.1016\/0278-2391(92)90495-l","journal-title":"J Oral Maxillofac Surg"},{"key":"ref46","article-title":"Complications and side effects of hyperbaric oxygen therapy","volume":"71","author":"Plafki C","year":"2000","unstructured":"Plafki C, Peters P, Almeling M, Welslau W, Busch R. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med. 2000, 71:119-24.","journal-title":"Aviat Space Environ Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-015-0035-4","article-title":"Long-term experience of hyperbaric oxygen therapy for refractory radio- or chemotherapy-induced haemorrhagic cystitis","volume":"15","author":"Degener S","year":"2015","unstructured":"Degener S, Pohle A, Strelow H, Mathers MJ, Zumb\u00e9 J, Roth S, Brandt AS. Long-term experience of hyperbaric oxygen therapy for refractory radio- or chemotherapy-induced haemorrhagic cystitis. BMC Urol. 2015, 15:38. 10.1186\/s12894-015-0035-4","journal-title":"BMC Urol"},{"key":"ref48","unstructured":"Radiation cystitis - overview. Guy\u2019s and St Thomas\u2019 NHS Foundation Trust. (2024). Accessed. October 5, 2024: https:\/\/www.guysandstthomas.nhs.uk\/our-services\/radiation-cystitis."},{"key":"ref49","unstructured":"London Hyperbaric Medicine Private Care. (2024). Accessed. September 18, 2024: https:\/\/lhmhealthcare.com\/private-care\/."},{"key":"ref50","unstructured":"James Paget University Hospitals NHS Foundation Trust. (2020). Accessed. 2024: https:\/\/www.jpaget.nhs.uk\/departments-services\/departments-services-a-z\/hyperbaric-chamber\/."},{"key":"ref51","unstructured":"Head and Neck Leaflets. Torbay and South Devon NHS Foundation Trust. (2024). Accessed: August 1, 2024: https:\/\/www.torbayandsouthdevon.nhs.uk\/about-us\/news-and-publications\/information-leaflets\/head-and-neck\/."},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)51405-6","article-title":"Intractable hematuria and formalin","volume":"130","author":"Godec CJ","year":"1983","unstructured":"Godec CJ, Gleich P. Intractable hematuria and formalin. J Urol. 1983, 130:688-91. 10.1016\/s0022-5347(17)51405-6","journal-title":"J Urol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1969.tb49656.x","article-title":"A method of management of inoperable carcinoma of the bladder","volume":"1","author":"Brown RB","year":"1969","unstructured":"Brown RB. A method of management of inoperable carcinoma of the bladder. Med J Aust. 1969, 1:23-4. 10.5694\/j.1326-5377.1969.tb49656.x","journal-title":"Med J Aust"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.4047","article-title":"Intravesical formalin for hemorrhagic cystitis: a contemporary cohort","volume":"11","author":"Ziegelmann MJ","year":"2017","unstructured":"Ziegelmann MJ, Boorjian SA, Joyce DD, Montgomery BD, Linder BJ. Intravesical formalin for hemorrhagic cystitis: a contemporary cohort. Can Urol Assoc J. 2017, 11:E79-82. 10.5489\/cuaj.4047","journal-title":"Can Urol Assoc J"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)56303-x","article-title":"Ureteral complications after intravesical formalin instillation","volume":"1","author":"Fall M","year":"1979","unstructured":"Fall M, Pettersson S. Ureteral complications after intravesical formalin instillation. J Urol. 1979, 1:160-2. 10.1016\/s0022-5347(17)56303-x","journal-title":"J Urol"},{"key":"ref56","unstructured":"National Cancer Institute. formaldehyde and cancer risk . (2025). Accessed: January 25, 2025: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/substances\/formaldehyde\/formaldehyde-fact-sheet."},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010165","article-title":"The carcinogenic effects of formaldehyde occupational exposure: a systematic review","volume":"14","author":"Protano C","year":"2021","unstructured":"Protano C, Buomprisco G, Cammalleri V, et al.. The carcinogenic effects of formaldehyde occupational exposure: a systematic review. Cancers (Basel). 2021, 14:165. 10.3390\/cancers14010165","journal-title":"Cancers (Basel)"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.aju.2018.01.004","article-title":"Selective embolisation for intractable bladder haemorrhages: a systematic review of the literature","volume":"16","author":"Taha DE","year":"2018","unstructured":"Taha DE, Shokeir AA, Aboumarzouk OA. Selective embolisation for intractable bladder haemorrhages: a systematic review of the literature. Arab J Urol. 2018, 16:197-205. 10.1016\/j.aju.2018.01.004","journal-title":"Arab J Urol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.01.003","article-title":"Outcome of transcatheter arterial embolization for bladder and prostate hemorrhage","volume":"183","author":"Delgal A","year":"2010","unstructured":"Delgal A, Cercueil JP, Koutlidis N, et al.. Outcome of transcatheter arterial embolization for bladder and prostate hemorrhage. J Urol. 2010, 183:1947-53. 10.1016\/j.juro.2010.01.003","journal-title":"J Urol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-018-2604-0","article-title":"Superselective vesical artery embolization in the management of intractable hematuria secondary to hemorrhagic cystitis","volume":"37","author":"Mohan S","year":"2019","unstructured":"Mohan S, Kumar S, Dubey D, Phadke RV, Baijal SS, Kathuria M. Superselective vesical artery embolization in the management of intractable hematuria secondary to hemorrhagic cystitis. World J Urol. 2019, 37:2175-82. 10.1007\/s00345-018-2604-0","journal-title":"World J Urol"},{"key":"ref61","unstructured":"National Institute for Health and Care Excellence. recommendations | bladder cancer: diagnosis and management. (2015). Accessed: January 12, 2025: https:\/\/www.nice.org.uk\/guidance\/ng2\/chapter\/Recommendations."},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2022.03.605","article-title":"Clinical outcomes following percutaneous urinary diversion for hemorrhagic cystitis","volume":"33","author":"Farhan A","year":"2022","unstructured":"Farhan A, Lyons GR. Clinical outcomes following percutaneous urinary diversion for hemorrhagic cystitis. J Vasc Interv Radiol. 2022, 33:841-4. 10.1016\/j.jvir.2022.03.605","journal-title":"J Vasc Interv Radiol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.06.030","article-title":"Cystectomy for refractory hemorrhagic cystitis: contemporary etiology, presentation and outcomes","volume":"192","author":"Linder BJ","year":"2014","unstructured":"Linder BJ, Tarrell RF, Boorjian SA. Cystectomy for refractory hemorrhagic cystitis: contemporary etiology, presentation and outcomes. J Urol. 2014, 192:1687-92. 10.1016\/j.juro.2014.06.030","journal-title":"J Urol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.03.056","article-title":"Fate of the leftover bladder after supravesical urinary diversion for benign disease","volume":"176","author":"Fazili T","year":"2006","unstructured":"Fazili T, Bhat TR, Masood S, Palmer JH, Mufti GR. Fate of the leftover bladder after supravesical urinary diversion for benign disease. J Urol. 2006, 176:620-1. 10.1016\/j.juro.2006.03.056","journal-title":"J Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/404285-the-practical-management-of-intractable-haematuria-within-the-national-health-service-of-the-united-kingdom-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:20:57Z","timestamp":1762269657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/404285-the-practical-management-of-intractable-haematuria-within-the-national-health-service-of-the-united-kingdom-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":64,"URL":"https:\/\/doi.org\/10.7759\/cureus.96083","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,4]]}}}